Abeona Therapeutics Inc.ABEONASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank71
3Y CAGR+112.0%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+112.0%/yr
vs -67.2%/yr prior
Acceleration
+179.2pp
Accelerating
Percentile
P71
Within normal range
vs 3Y Ago
9.5x
Strong expansion
Streak
4 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$4.29M+47.5%
2024$2.91M+81.1%
2023$1.60M+256.7%
2022$450000.00-
2021$0.00-
2020$0.00-100.0%
2019$48.57M+25.5%
2018$38.70M+127.8%
2017$16.99M+59.4%
2016$10.65M-